PRECISION BIOSCIENCES INC Noncash or Part Noncash Acquisition, Intangible Assets Acquired
PRECISION BIOSCIENCES INC (DTIL) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $200.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2026-08-06
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-06-30 was $0.00.
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2026-03-31 was $200.00K.
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-06-30 was $0.00.
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2025-03-31 was $0.00.
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for fiscal 2025 was $300.00K, a 20.00% increase from fiscal 2024.
- PRECISION BIOSCIENCES INC noncash or part noncash acquisition, intangible assets acquired for fiscal 2024 was $250.00K.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $200.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | $300.00K 10-K · filed 2026-03-12 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | $250.00K 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |